| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.58 | 0.003 | 0.58 | HIV-1 reverse transcriptase inhibitor | 0.305 0.005 CID_131769929 | ||
| 0.484 | 0.001 | 0.484 | Nicotinic acid receptor 1 agonist | |||
| 0.473 | 0.012 | 0.473 | RNA-directed DNA polymerase inhibitor | 0.436 0.015 CID_131769929 | ||
| 0.479 | 0.044 | 0.479 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.329 | 0.006 | 0.329 | DNA directed RNA polymerase inhibitor | 0.193 0.015 CID_131769929 | ||
| 0.322 | 0.012 | 0.322 | Phosphodiesterase inhibitor | |||
| 0.364 | 0.082 | 0.364 | MAP kinase kinase 6 inhibitor | |||
| 0.324 | 0.049 | 0.324 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.285 | 0.033 | 0.285 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.265 | 0.053 | 0.265 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.263 | 0.051 | 0.263 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.242 | 0.051 | 0.242 | TRKC antagonist | |||
| 0.227 | 0.053 | 0.227 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.177 | 0.009 | 0.177 | Cyclin B3 inhibitor | |||
| 0.221 | 0.058 | 0.221 | Nitric-oxide synthase stimulant | 0.192 0.102 CID_131769929 | ||
| 0.172 | 0.01 | 0.172 | Phosphodiesterase 4B inhibitor | |||
| 0.192 | 0.033 | 0.192 | Glycogen synthase kinase-3 inhibitor | |||
| 0.168 | 0.01 | 0.168 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.174 | 0.017 | 0.174 | Phosphodiesterase IV inhibitor | |||
| 0.182 | 0.033 | 0.182 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.153 | 0.01 | 0.153 | Phosphodiesterase V inhibitor | |||
| 0.203 | 0.061 | 0.203 | LIM domain kinase 1 inhibitor | |||
| 0.151 | 0.01 | 0.151 | Phosphodiesterase 5A inhibitor | |||
| 0.164 | 0.023 | 0.164 | Death-associated protein kinase 1 inhibitor | |||
| 0.175 | 0.045 | 0.175 | Cyclin-dependent kinase inhibitor | |||
| 0.2 | 0.075 | 0.2 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.212 | 0.09 | 0.212 | MAP kinase kinase 3 inhibitor | |||
| 0.195 | 0.08 | 0.195 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.11 | 0.004 | 0.11 | Nicotinic acid receptor agonist | |||
| 0.171 | 0.066 | 0.171 | Death-associated protein kinase 2 inhibitor | |||
| 0.139 | 0.042 | 0.139 | 5 Hydroxytryptamine 3A agonist | |||
| 0.121 | 0.027 | 0.121 | Phosphodiesterase I inhibitor | |||
| 0.117 | 0.025 | 0.117 | Bromodomain-containing protein 2 inhibitor | |||
| 0.105 | 0.013 | 0.105 | CDK4/cyclin D1 inhibitor | |||
| 0.099 | 0.01 | 0.099 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.093 | 0.009 | 0.093 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.097 | 0.015 | 0.097 | CDK4/cyclin D inhibitor | |||
| 0.147 | 0.066 | 0.147 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.201 | 0.121 | 0.332 | DNA synthesis inhibitor | 0.332 0.034 CID_131769929 | CID_131769929 | |
| 0.148 | 0.069 | 0.148 | Activin receptor-like kinase 2 inhibitor | |||
| 0.144 | 0.069 | 0.144 | Ribosomal protein S6 kinase inhibitor | |||
| 0.149 | 0.076 | 0.149 | Acetylcholine M1 receptor antagonist | |||
| 0.133 | 0.063 | 0.133 | Glutamate receptor antagonist | |||
| 0.283 | 0.213 | 0.283 | Caspase 9 stimulant | 0.28 0.217 CID_131769929 | ||
| 0.095 | 0.025 | 0.095 | Phosphodiesterase III inhibitor | |||
| 0.084 | 0.018 | 0.084 | Cyclin B1 inhibitor | |||
| 0.086 | 0.021 | 0.086 | Phosphodiesterase VII inhibitor | |||
| 0.075 | 0.01 | 0.075 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.165 | 0.1 | 0.165 | MAP kinase kinase 5 inhibitor | |||
| 0.079 | 0.015 | 0.079 | Cyclin B2 inhibitor | |||
| 0.078 | 0.018 | 0.078 | AMPA receptor antagonist | |||
| 0.095 | 0.036 | 0.095 | Phosphodiesterase 3A inhibitor | |||
| 0.162 | 0.106 | 0.162 | Death-associated protein kinase 3 inhibitor | |||
| 0.106 | 0.05 | 0.106 | Electrolyte absorption antagonist | |||
| 0.075 | 0.02 | 0.075 | Phosphodiesterase II inhibitor | |||
| 0.149 | 0.097 | 0.149 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.081 | 0.029 | 0.081 | Protein kinase C beta inhibitor | |||
| 0.102 | 0.051 | 0.102 | CDK/cyclin complex inhibitor | |||
| 0.113 | 0.063 | 0.113 | Polo-like kinase-4 inhibitor | |||
| 0.104 | 0.053 | 0.104 | Protein kinase C mu inhibitor | |||
| 0.072 | 0.022 | 0.072 | Phosphodiesterase 1A inhibitor | |||
| 0.062 | 0.013 | 0.062 | Benzodiazepine inverse agonist | |||
| 0.07 | 0.022 | 0.07 | Cyclin B inhibitor | |||
| 0.105 | 0.058 | 0.105 | Bronchodilator | |||
| 0.074 | 0.027 | 0.074 | Transcription factor AP-1 inhibitor | 0.071 0.029 CID_131769929 | ||
| 0.127 | 0.08 | 0.127 | Tyrosine-protein kinase receptor antagonist | |||
| 0.108 | 0.061 | 0.108 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.055 | 0.009 | 0.055 | Calcitonin gene-related peptide antagonist | |||
| 0.139 | 0.094 | 0.139 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.065 | 0.021 | 0.065 | Phosphodiesterase 2A inhibitor | |||
| 0.108 | 0.064 | 0.108 | Protein kinase C gamma inhibitor | |||
| 0.062 | 0.02 | 0.062 | Phosphodiesterase 7A inhibitor | |||
| 0.089 | 0.049 | 0.089 | Inducible nitric-oxide synthase inhibitor | |||
| 0.1 | 0.062 | 0.1 | mTOR complex 1 inhibitor | |||
| 0.101 | 0.063 | 0.105 | Folate antagonist | 0.105 0.057 CID_131769929 | CID_131769929 | |
| 0.05 | 0.013 | 0.05 | MAP3K5 inhibitor | |||
| 0.075 | 0.039 | 0.075 | CDC7 inhibitor | |||
| 0.04 | 0.005 | 0.04 | Phosphodiesterase IX inhibitor | |||
| 0.07 | 0.036 | 0.07 | DNA gyrase inhibitor | |||
| 0.038 | 0.005 | 0.038 | Phosphodiesterase 9A inhibitor | |||
| 0.11 | 0.077 | 0.11 | TRKA antagonist | |||
| 0.041 | 0.012 | 0.041 | CDK6/cyclin D3 inhibitor | |||
| 0.077 | 0.047 | 0.084 | Phosphodiesterase VI inhibitor | 0.084 0.035 CID_131769929 | CID_131769929 | |
| 0.038 | 0.009 | 0.038 | DNA topoisomerase IV inhibitor | |||
| 0.105 | 0.077 | 0.105 | Acetylcholine release stimulant | |||
| 0.049 | 0.022 | 0.049 | CDK5/p25 inhibitor | |||
| 0.047 | 0.02 | 0.047 | DNA gyrase subunit A inhibitor | |||
| 0.084 | 0.058 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.058 | 0.034 | 0.058 | Bromodomain-containing protein 4 inhibitor | |||
| 0.072 | 0.048 | 0.072 | Benzodiazepine agonist | |||
| 0.028 | 0.005 | 0.028 | Progesterone receptor B antagonist | |||
| 0.073 | 0.05 | 0.073 | Polo-like kinase-2 inhibitor | |||
| 0.048 | 0.027 | 0.048 | Phosphodiesterase 3B inhibitor | |||
| 0.06 | 0.039 | 0.06 | Cyclin A1 inhibitor | |||
| 0.063 | 0.043 | 0.063 | 5 Hydroxytryptamine 3 agonist | |||
| 0.106 | 0.086 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.056 | 0.037 | 0.056 | Protein kinase C eta inhibitor | 0.05 0.044 CID_131769929 | ||
| 0.035 | 0.018 | 0.035 | Protein kinase C beta I inhibitor | 0.034 0.022 CID_131769929 | ||
| 0.078 | 0.065 | 0.078 | MAP-kinase-activated kinase inhibitor | |||
| 0.017 | 0.004 | 0.017 | Cyclin D2 inhibitor | |||
| 0.064 | 0.052 | 0.064 | Protein kinase C alpha inhibitor | |||
| 0.039 | 0.028 | 0.039 | Cyclin D3 inhibitor | |||
| 0.077 | 0.066 | 0.077 | Phosphodiesterase 11A inhibitor | |||
| 0.077 | 0.066 | 0.077 | Phosphodiesterase XI inhibitor | |||
| 0.029 | 0.019 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.018 | 0.01 | 0.018 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.154 | 0.146 | 0.189 | Cyclic AMP phosphodiesterase inhibitor | 0.189 0.103 CID_131769929 | CID_131769929 | |
| 0.053 | 0.045 | 0.053 | Glutamate (mGluR1) antagonist | |||
| 0.055 | 0.05 | 0.055 | Phosphodiesterase 1B inhibitor | |||
| 0.081 | 0.075 | 0.081 | Protein kinase C delta inhibitor | |||
| 0.028 | 0.024 | 0.028 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.134 | 0.13 | 0.134 | Clk dual-specificity kinase inhibitor | |||
| 0.071 | 0.07 | 0.071 | Acetylcholine M3 receptor agonist | |||
| 0.066 | 0.065 | 0.066 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.188 | 0.222 | 0.574 | Antiobesity | 0.574 0.024 CID_131769929 | CID_131769929 | |
| 0.058 | 0.128 | 0.148 | Mediator release inhibitor | 0.148 0.029 CID_131769929 | CID_131769929 | |
| 0.072 | 0.145 | 0.112 | Phosphodiesterase 6D inhibitor | 0.112 0.033 CID_131769929 | CID_131769929 | |
| 0.071 | 0.146 | 0.097 | Multidrug resistance-associated protein 1 inhibitor | 0.097 0.085 CID_131769929 | CID_131769929 | |
| 0.09 | 0.18 | 0.17 | Hexokinase inhibitor | 0.17 0.058 CID_131769929 | CID_131769929 | |
| 0.162 | 0.261 | 0.494 | Histamine release inhibitor | 0.494 0.031 CID_131769929 | CID_131769929 | |
| 0.085 | 0.207 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 CID_131769929 | CID_131769929 | |
| 0.088 | 0.214 | 0.219 | Hemostatic | 0.219 0.027 CID_131769929 | CID_131769929 | |
| 0.058 | 0.185 | 0.143 | Beta glucuronidase inhibitor | 0.143 0.028 CID_131769929 | CID_131769929 | |
| 0.189 | 0.326 | 0.285 | 5 Hydroxytryptamine release inhibitor | 0.285 0.183 CID_131769929 | CID_131769929 | |
| 0.048 | 0.188 | 0.119 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 CID_131769929 | CID_131769929 | |
| 0.015 | 0.178 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 CID_131769929 | CID_131769929 | |
| 0.1 | 0.285 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.045 CID_131769929 | CID_131769929 | |
| 0.083 | 0.287 | 0.199 | Vasodilator | 0.199 0.106 CID_131769929 | CID_131769929 | |
| 0.132 | 0.349 | 0.357 | Interleukin 2 agonist | 0.357 0.043 CID_131769929 | CID_131769929 | |
| 0.066 | 0.29 | 0.223 | Interleukin agonist | 0.223 0.1 CID_131769929 | CID_131769929 | |
| 0.074 | 0.317 | 0.152 | Interferon gamma antagonist | 0.152 0.075 CID_131769929 | CID_131769929 | |
| 0.031 | 0.278 | 0.121 | Topoisomerase II inhibitor | 0.121 0.066 CID_131769929 | CID_131769929 | |
| 0.13 | 0.402 | 0.772 | Cyclophilin D inhibitor | 0.772 0.008 CID_131769929 | CID_131769929 | |
| 0.037 | 0.322 | 0.084 | NADH dehydrogenase inhibitor | 0.084 0.066 CID_131769929 | CID_131769929 | |
| 0.008 | 0.322 | 0.081 | Antineoplastic antibiotic | 0.081 0.057 CID_131769929 | CID_131769929 | |
| 0.047 | 0.368 | 0.088 | Interleukin 12 antagonist | 0.088 0.077 CID_131769929 | CID_131769929 | |
| 0.029 | 0.351 | 0.187 | AMP-activated protein kinase stimulant | 0.187 0.013 CID_131769929 | CID_131769929 | |
| 0.081 | 0.429 | 0.474 | Immunomodulator | 0.474 0.027 CID_131769929 | CID_131769929 | |
| 0.028 | 0.389 | 0.205 | Thrombolytic | 0.205 0.05 CID_131769929 | CID_131769929 | |
| 0.075 | 0.464 | 0.499 | Antibacterial | 0.499 0.041 CID_131769929 | CID_131769929 | |
| 0.017 | 0.418 | 0.108 | Topoisomerase I inhibitor | 0.108 0.064 CID_131769929 | CID_131769929 | |
| 0.042 | 0.456 | 0.27 | Tumour necrosis factor alpha release inhibitor | 0.27 0.066 CID_131769929 | CID_131769929 | |
| 0.011 | 0.447 | 0.073 | Protein 50S ribosomal subunit inhibitor | 0.073 0.023 CID_131769929 | CID_131769929 | |
| 0.029 | 0.476 | 0.145 | Hypolipemic | 0.145 0.142 CID_131769929 | CID_131769929 | |
| 0.025 | 0.497 | 0.24 | Immunostimulant | 0.24 0.1 CID_131769929 | CID_131769929 | |
| 0.073 | 0.551 | 0.342 | Apoptosis agonist | 0.342 0.144 CID_131769929 | CID_131769929 | |
| 0.026 | 0.522 | 0.166 | Platelet antagonist | 0.166 0.129 CID_131769929 | CID_131769929 | |
| 0.066 | 0.576 | 0.305 | Apoptosis antagonist | 0.305 0.082 CID_131769929 | CID_131769929 | |
| 0.039 | 0.55 | 0.28 | Transcription factor NF kappa B inhibitor | 0.28 0.106 CID_131769929 | CID_131769929 | |
| 0.081 | 0.593 | 0.323 | Peptidyltransferase inhibitor | 0.323 0.018 CID_131769929 | CID_131769929 | |
| 0.04 | 0.564 | 0.155 | NOS3 expression enhancer | 0.155 0.067 CID_131769929 | CID_131769929 | |
| 0.027 | 0.565 | 0.156 | Insulin secretagoues | 0.156 0.069 CID_131769929 | CID_131769929 | |
| 0.015 | 0.565 | 0.11 | Lipid peroxidase inhibitor | 0.11 0.105 CID_131769929 | CID_131769929 | |
| 0.02 | 0.57 | 0.419 | Angiogenesis stimulant | 0.419 0.019 CID_131769929 | CID_131769929 | |
| 0.062 | 0.64 | 0.567 | Antiinflammatory | 0.567 0.063 CID_131769929 | CID_131769929 | |
| 0.026 | 0.655 | 0.264 | Antithrombotic | 0.264 0.115 CID_131769929 | CID_131769929 | |
| 0.024 | 0.705 | 0.302 | Immunosuppressant | 0.302 0.113 CID_131769929 | CID_131769929 | |
| 0.025 | 0.722 | 0.09 | Transcription factor NF kappa B stimulant | 0.09 0.052 CID_131769929 | CID_131769929 | |
| 0.009 | 0.724 | 0.053 | Antibiotic Aminoglycoside-like | 0.053 0.012 CID_131769929 | CID_131769929 | |
| 0.01 | 0.782 | 0.184 | Nitric oxide antagonist | 0.184 0.074 CID_131769929 | CID_131769929 | |
| 0.016 | 0.792 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.083 CID_131769929 | CID_131769929 | |
| 0.008 | 0.792 | 0.272 | Antioxidant | 0.272 0.073 CID_131769929 | CID_131769929 | |
| 0.012 | 0.851 | 0.152 | Platelet adhesion inhibitor | 0.152 0.103 CID_131769929 | CID_131769929 | |
| 0.004 | 0.873 | 0.183 | Selectin antagonist | 0.183 0.013 CID_131769929 | CID_131769929 | |
| 0.005 | 0.883 | 0.227 | Free radical scavenger | 0.227 0.079 CID_131769929 | CID_131769929 | |
| 0.01 | 0.894 | 0.38 | Hypoglycemic | 0.38 0.031 CID_131769929 | CID_131769929 | |
| 0.014 | 0.908 | 0.224 | Hepatoprotectant | 0.224 0.053 CID_131769929 | CID_131769929 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |